The Inspiration and Truth behind Seattle Genetics; Dr. Clay Siegall

Dr. Siegall is one of the most reliable medical practitioners with a vast knowledge and experience in the field. Well, this did not come as easy as it is said. As he revealed during an interview the idea of establishing a private venture, Seattle Genetics came from his desire for altitude in his career. He also had a desire for medicine, probably coming up with something new and effective in the field, power of technology and unexplored world of some medicine.

Motivated by the desire to see a reversal of those entitled to death due to medical condition have life in abundance all over again. An experience with a family member diagnosed with cancer made him realize that some treatment options are not as effective as they are thought to be. Chemotherapy, for instance, is more draining as compared to amputation and radical surgery which are minimally invasive. This is how Seattle Genetics was formed.

Along with other senior researchers, he did dive into fact-finding about the abnormal growth of cells and how this growth would be contained and treated without having to expose the patient to more adverse effects of heat treatment. Their main mode of treatment is targeted therapy or systemic chemotherapies. Seattle has developed an antibody-drug known as ADCetris which is the first ever FDA approved the drug. This is their best seller and probably won’t be beaten by competitors’ equals. Another awaiting introduction is in partnership with Genentech, Pfizer, and Bayer.

About Dr. Clay Siegall

Dr. Clay Siegall is the Chief Executive Officer of the Seattle based technology company, Seattle Genetics. This firm uses targeted therapy drugs which are more effective than conventional treatment methods. Sharing in his big dream for Seattle Genetics and hunger for a lasting solution, research has extensively been done, trial and experiments conducted.

He revealed he made quite a fortune from Seattle Genetics from selling their drugs and also from drug production partnerships with other legalized companies. The blossom came after their Initial public offer. Dr. Clay Siegall is a Bachelor of Science degree holder in zoology from the University of Maryland and obtained a merited Ph.D. from his alma mater, George Washington University in Genetics.

Leave a Reply

Your email address will not be published. Required fields are marked *